作者: Karine Lester , Martine Cerruti , Severine Loisel , Laurence Boumsell , Christian Berthou
DOI:
关键词: CD5 、 Immunology 、 T cell 、 Graft rejection 、 Antibody 、 Transplantation 、 HLA-DR 、 Lymphoma 、 Biology
摘要: The present invention relates to compositions containing antibodies for treating CD5+ HLA-DR+ B OR T cell related diseases such as or malignances (leukaemia and lymphoma), autoimmune transplantation graft rejection.